The Global Biobanking Market is expected to grow by $ 1.28 bn during 2021-2025, progressing at a CAGR of 8.44% during the forecast period

·3 min read

Global Biobanking Market 2021-2025 The analyst has been monitoring the biobanking market and it is poised to grow by $ 1. 28 bn during 2021-2025, progressing at a CAGR of 8. 44% during the forecast period.

New York, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Biobanking Market 2021-2025" - https://www.reportlinker.com/p02840420/?utm_source=GNW
Our report on the biobanking market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing demand for personalized medicine and increase in efficiency through automation will increase demand. In addition, the growing demand for personalized medicine is anticipated to boost the growth of the market as well.
The biobanking market analysis includes the product segment and geographic landscape.

The biobanking market is segmented as below:
By Product
• Equipment
• Consumables

By Geographical Landscape
• North America
• Europe
• Asia
• ROW

This study identifies the reduction in research costsas one of the prime reasons driving the biobanking market growth during the next few years.

The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on biobanking market covers the following areas:
• Biobanking market sizing
• Biobanking market forecast
• Biobanking market industry analysis

This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biobanking market vendors that include AMS Biotechnology (Europe) Ltd., ASKION GmbH, Bay Biosciences LLC, Cureline Inc., Firalis SA, GENETICIST Inc., Hamilton Bonaduz AG, ProteoGenex Inc., Thermo Fisher Scientific Inc., and US Biolab Corp. Inc. Also, the biobanking market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Read the full report: https://www.reportlinker.com/p02840420/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting